Health > Cancers > Multiple Myeloma

Cancer Centers Program

Download applications (.PDF format) for competing grants / non-competing grants NCI-ASCO Cancer Foundation Clinical Investigator Team Leadership Award It is the intent of the Cancer Clinical Investigator Team Leadership Award to support mid-level ...More…

Cáncer metastático - National Cancer Institute

National Cancer Institute — El cáncer se presenta cuando las células se hacen anormales y crecen sin control (vea la pregunta 1). El lugar donde se inició el cáncer se denomina cáncer primario o tumor primario (vea la pregunta 2). El cáncer metastático se presenta cuando ...More…

What You Need To Know About Multiple Myeloma

National Institutes of Health (Cancer) — This booklet is only about multiple myeloma. It is not about bone cancer. Although multiple myeloma affects the bones, it begins in plasma cells. Bone cancer begins in bone cells. It's diagnosed and treated differently from multiple myeloma. The ...More…

Thalidomide Continues its Comeback Against Multiple Myeloma

National Institutes of Health (Cancer) — The drug thalidomide continues to show promise as a treatment for the resilient blood cancer called multiple myeloma, researchers said Tuesday at the 2000 American Society of Clinical Oncology annual meeting. Their results confirm a smaller study ...More…

Multiple Myeloma/Other Plasma Cell Neoplasms

National Institutes of Health (Cancer) — What You Need To Know About Multiple Myeloma to learn about multiple myeloma symptoms, diagnosis, treatment, and questions to ask the doctor. : A type of cancer that begins in plasma cells (white blood cells that produce antibodies). Also called ...More…

Multiple Myeloma and Other Plasma Cell Neoplasms Treatment

National Institutes of Health (Cancer) — Multiple myeloma and other plasma cell neoplasms (cancers) are diseases in which the body makes too many plasma cells. Multiple myeloma and other plasma cell neoplasms may cause a condition called amyloidosis. Age can affect the risk of ...More…

Mieloma múltiple y otras neoplasias de células ...

National Institutes of Health (Cancer) — Gammapatía monoclonal de significación indeterminada (GMSI) Ciertos factores influyen en el pronóstico (probabilidad de recuperación) y las opciones de tratamiento. Un tumor puede dañar los huesos y causar hipercalcemia, (un trastorno que se ...More…

High-Dose Chemotherapy With Stem-Cell Transplantation ...

National Cancer Institute — Multiple myleloma, high-dose chemotherapy, autologous stem-cell transplantation. (Definitions of many terms related to cancer can be found in the Cancer.gov Dictionary.) In this randomized trial, multiple myeloma patients treated with high-dose ...More…

autologous transplants

National Cancer Institute — Hematopoietic or blood-forming stem cells are immature cells that can mature into blood cells. These stem cells are found in the bone marrow, bloodstream, or umbilical cord blood (see Question 1). Bone marrow transplantation (BMT) and peripheral ...More…

Lower Dose of Thalidomide May Be Just as Effective in ...

National Cancer Institute — Multiple myeloma, thalidomide. (Definitions of many terms related to cancer can be found in the Cancer.gov Dictionary.) Cutting the daily dose of the drug thalidomide from 400 mg to 100 mg significantly reduced the drug's potentially severe side ...More…

Tumor Grade: Q & A; - National Cancer Institute

National Cancer Institute — Tumor grade is a system used to classify cancer cells in terms of how abnormal they look under a microscope and how quickly the tumor is likely to grow and spread (see Question 2). A pathologist (a doctor who identifies diseases by studying cells ...More…

Thalidomide Beneficial for Older Multiple Myeloma Patients

National Cancer Institute — Multiple myeloma, thalidomide, melphalan, prednisone. (Definitions of many terms related to cancer can be found in the Cancer.gov Dictionary.) In this phase III clinical trial, older patients most over the age of 65 with previously untreated ...More…